Yaping Zhang on Two-Way GPIb-IX Signaling in Platelet Activation and VWF Binding
Yaping Zhang, Postdoc Associate at University of Illinois Chicago, shared on LinkedIn:
”Applaud everyone!
I am proud to share that our NEW paper “Direct Binding of Lyn to GPIbβ Transmits Two-Way GPIb-IX Signaling to Stimulate Platelet Activation and VWF Binding”, is published in Circulation Research and ONLINE today!
Yaping Zhang, Ying Liang, Amir Hossein Kazemipour Ashkezari, Can Wang, Claire Chang, Yanyan Bai, Xin Huang, Andrew Mack, Haotian Yang, Peiwen Cong, Ni Cheng, Cheng Zhu, and Xiaoping Du
A huge thank you to all my co-authors listed above who helped me publish this work!
Especially thanks to our collaborator Dr. Cheng Zhu’s group from the Georgia Institute of Technology (Amir Hossein Kazemipour Ashkezari and Dr. Peiwen Cong) for their contributions.
We also thank the reviewers and editors from Circulation Research for your support and publication of our work.
Novelty and Significance
•This article demonstrates that Lyn directly binds to the GPIb (glycoprotein Ib) β subunit at the transmembrane-cytoplasmic domain interface.
•This article shows that this Lyn-GPIbβ interaction is essential for bidirectional GPIb-IX signaling that strengthens GPIb-IX-VWF interaction and mediates platelet activation and aggregation in response to VWF and collagen.
•This article invents a novel peptide drug that blocks Lyn binding to GPIbβ and inhibits platelet adhesion/aggregation and arterial thrombosis with potential for treating thrombotic diseases.”
Read the full article in Circulation Research.
Article: Direct Binding of Lyn to GPIbβ Transmits Two-Way GPIb-IX Signaling to Stimulate Platelet Activation and VWF Binding
Authors: Yaping Zhang, Ying Liang, Amir Hossein Kazemipour Ashkezari, Can Wang, Claire Chang, Yanyan Bai, Xin Huang, Andrew Mack, Haotian Yang, Peiwen Cong, Ni Cheng, Cheng Zhu, Xiaoping Du

Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial